Thrivent Financial for Lutherans
RCUS icon

Thrivent Financial for Lutherans’s Arcus Biosciences RCUS Stock Holding History

Thrivent Financial for Lutherans’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51M Sell
69,875
-10,518
-13% -$227K ﹤0.01% 1640
2025
Q4 		$1.92M Buy
80,393
+30,484
+61% +$622K ﹤0.01% 1520
2025
Q3 		$679K Buy
49,909
+79
+0.2% +$821 ﹤0.01% 1968
2025
Q2 		$406K Buy
49,830
+401
+0.8% +$3.42K ﹤0.01% 2221
2025
Q1 		$388K Buy
49,429
+7,696
+18% +$89.2K ﹤0.01% 2159
2024
Q4 		$621K Sell
41,733
-627
-1% -$10.2K ﹤0.01% 2164
2024
Q3 		$648K Sell
42,360
-2,943
-6% -$46.4K ﹤0.01% 2138
2024
Q2 		$690K Sell
45,303
-1,592
-3% -$25.7K ﹤0.01% 2067
2024
Q1 		$885K Sell
46,895
-1,131
-2% -$19.6K ﹤0.01% 1961
2023
Q4 		$917K Sell
48,026
-1,046
-2% -$16.7K ﹤0.01% 1893
2023
Q3 		$881K Sell
49,072
-1,281
-3% -$25.7K ﹤0.01% 1830
2023
Q2 		$1.02M Sell
50,353
-1,312
-3% -$25K ﹤0.01% 1787
2023
Q1 		$942K Sell
51,665
-1,811
-3% -$34.6K ﹤0.01% 1823
2022
Q4 		$1.11M Sell
53,476
-231
-0.4% -$6.36K ﹤0.01% 1661
2022
Q3 		$1.41M Buy
53,707
+7,908
+17% +$209K ﹤0.01% 1458
2022
Q2 		$1.16M Buy
+45,799
New +$1.12M ﹤0.01% 1611

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Thrivent Financial for Lutherans's RCUS Position: Q1 2026 in Review

Thrivent Financial for Lutherans reduced its Arcus Biosciences (RCUS) stake by 13% in Q1 2026, selling an estimated $227K and leaving 69,875 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Thrivent Financial for Lutherans first reported a position in RCUS in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.92M in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Thrivent Financial for Lutherans held 69,875 shares of Arcus Biosciences worth $1.51M as of Q1 2026.
  • Thrivent Financial for Lutherans sold 10,518 Arcus Biosciences shares in Q1 2026, an estimated $227K.
  • Arcus Biosciences made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1640 holding.
  • Thrivent Financial for Lutherans first reported a position in Arcus Biosciences in Q2 2022 and has held it in 16 quarters since.
  • Thrivent Financial for Lutherans's Arcus Biosciences position peaked at $1.92M in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.